The company is preparing to submit the results to the FDA this year Orca Bio has shared...
Medicine
Abzena has appointed Taylor Boyd as Chief Business Officer Abzena has announced the appointment of Taylor Boyd...
The agency has launched a whole genome sequencing service to monitor the virus The UK Health Security...
How to choose the best telemedicine provider for neurology As hospitals navigate the evolving landscape of healthcare,...
Top 5 platforms for measurement-based care in 2025 Measurement-based care (MBC) enhances clinical and therapeutic outcomes through...
Immunoglobulin therapy improves mobility in phase 2/3 study Grifols has announced positive results from its phase 2/3...
EC extends brexpiprazole indication to include adolescents Otsuka Pharmaceutical Europe and Lundbeck have announced that the European...
Company seeks new direction after negative CHMP opinion on KIZFIZO Orphelia Pharma is exploring alternative regulatory pathways...
Phase 2a TREE study assesses safety and efficacy of leriglitazone Minoryx Therapeutics has dosed the first patient...
Oxford Medical Products targets overweight individuals Oxford Medical Products has announced positive three-month clinical trial results for...
CervoMed’s therapy demonstrates significant improvement in patients CervoMed has announced positive results from the extension phase 2b...
Scottish Medicines Consortium approves new option for mCRPC patients Pfizer Ltd has announced that the Scottish Medicines...
FSCD therapy meets all endpoints in interim analysis Agomab Therapeutics NV (Agomab) has announced positive interim results...
Octapharma supports NHS in building resilient supply chain Octapharma has announced that, for the first time in...
NICE convenes third committee meeting for additional appraisal consideration Eisai Europe Ltd. and Biogen Idec Ltd. announced...
Innovative digital transformation leads to significant improvements To reduce waiting lists and enhance patient communication, Rotherham NHS...
Cohort expansion phase commences with promising results The Safety Review Committee (SRC) has confirmed the end of...
Lead candidate for lung infections moves to human trials Centauri Therapeutics Limited has announced the selection of...
Kenvue appoints Bas Vorsteveld as Managing Director for Northern Europe Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe....
New research highlights NHS approval gap compared to other cancers Research from the Blood Cancer Alliance reveals...
Grünenthal has appointed Professor Dr Uli Brödl as CSO Grünenthal has announced that Professor Dr Uli Brödl will assume the role of Chief...
Pharmaceutical manufacturers in the UK have been navigating complex supply chains for the longest time, balancing the...
The critical step of navigating post-approval phase
New collaboration aims to integrate AI solutions for treatment Brainomix, a leader in stroke AI imaging software,...
New partnership to integrate SRD search technology Datapharm, a UK-based provider of medicines information, has announced its...
Updated data from phase 2 study reveals survival benefit Alligator Bioscience has announced updated results from its...
Data presented in Los Angeles showcases therapy’s potential Microbiotica, a clinical-stage biopharma company, has presented new data...
Awareness of interstitial lung disease raised at Miracle Garden Boehringer Ingelheim, a leading biopharmaceutical company, has teamed...
Former UK PM advocates for national screening programme Rishi Sunak has joined Prostate Cancer Research as an...
BC Platforms has appointed Mukhtar Ahmed as CEO BC Platforms has announced that it has appointed Mukhtar...
It is hoped that the approach will lead to more targeted treatments for childhood cancers Researchers from...
Carbogen Amcis has appointed Stephan Fritschi as CEO Carbogen Amcis has appointed Stephan Fritschi, who is currently...
Tenosynovial giant cell tumours can cause pain, stiffness, swelling and movement limitations The US Food and Drug...
Baxter has appointed Brent Shafer as Chair and Interim CEO Baxter International has appointed Brent Shafer, who...
The common heart condition affects approximately 1.5 million people in the UK A new UK study has...
Baxter has appointed Heather Knight as Executive Vice President and COO Baxter International has appointed Heather Knight,...
New data has shown that around a third of women do not attend screenings after being invited...
New funding to investigate cognitive decline and brain ageing The University of Bath has received a £3.5...
New test aims to revolutionise prostate cancer screening Scientists in Cambridge have developed a new ‘super test’...
Imaging agent to improve prostate cancer detection Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare...
Significant progress for hereditary angioedema condition Global biotechnology leader CSL has announced that the European Commission (EC)...
UCB’s BIMZELX reveals promising two-year data at EHSF 2025 UCB has announced impressive two-year data for BIMZELX...
Potential treatment for multiple system atrophy shows promise Lundbeck’s investigational drug, amlenetug, has been granted Fast Track...
Treatment expands options for HER2-negative metastatic breast cancer AstraZeneca announced that its drug Lynparza (olaparib) has been...
New immunotherapy offers hope for recurrent cervical cancer Regeneron UK Limited has announced that the Scottish Medicines...
CSL Behring’s study reveals significant long-term benefits New data from CSL Behring’s HOPE-B study demonstrates that Hemgenix...
New methodology may boost innovation in protein engineering Capgemini has introduced a pioneering generative AI-driven methodology for...
Designation follows promising preclinical data and FDA clearance Ariceum Therapeutics, a private biotech company based in Berlin,...
Partnership aims to leverage cutting-edge technology in clinical trials Qureight Ltd and Avalyn Pharma Inc have announced...
Breast cancer therapy offers hope for patients at risk of recurrence Novartis UK announced the Medicines and...
Sanofi’s Rippon Ubhi appointed new Chair of European Medicines Group Sanofi has announced that Rippon Ubhi has been appointed as...
Study shows AP-325 offers lasting pain relief without central side effects Algiax Pharmaceuticals, a company committed to...
Partnership aims to create recombinant nanobodies to treat immune disorders Grifols, a global healthcare company and leading...
Positive opinion issued for marketing authorisation extension The Committee for Medicinal Products for Human Use (CHMP) has...
Funding led by new investors FSG and EIC Fund Helsinki-based Aplagon has raised EUR 7 million to...
Diversity remains high on the agenda for those designing and delivering clinical trials with the aim of...
How the emc supports the accessibility of medicines information Distributing reliable information about medicines is challenging for...
Commit Biologics has appointed Janine Schuurman to its board Commit Biologics has announced the appointment of Janine Schuurman to its Board of...
Alliance Healthcare has appointed Paula Sutherland as Sales Director Alliance Healthcare UK has announced that Paula Sutherland has been appointed to the...
Patients and care partners may find once every four weeks maintenance dosing easier The US Food and...
Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25 Cartesian Therapeutics has secured an...
Comparison shows improved survival rates for pancreatic cancer treatment Alligator Bioscience has announced positive outcomes from indirect...
Study highlights VE303’s potential in reducing recurrent CDI Vedanta Biosciences has published additional results from its Phase...
Phase 3 trial shows promising pain relief for acute pain patients Tris Pharma, Inc. has announced positive...
Orphan drug designation offers development incentives and potential market exclusivity Zydus has announced that the USFDA has...
NICE endorses Imfinzi and Tagrisso for enhanced lung cancer care AstraZeneca has received two positive recommendations from...
Europe’s first biomarker trial seeks to prevent Crohn’s Disease onset In a landmark effort, the INTERCEPT project...
Combination therapy shows superior survival benefit over standard treatment The European Commission (EC) has approved the marketing...
Preclinical data highlights potential in treating Alzheimer’s disease AlzeCure Pharma AB announced that its abstract on NeuroRestore...
Collaboration aims to enhance accessibility of medicines information Datapharm has announced its expansion into the United States...
Cell and Gene Therapy Catapult reveals significant growth in UK trials The UK experienced a notable increase...
Companies aim to provide new treatments for inflammatory conditions Gilead Sciences and LEO Pharma have announced a...
Partnership aims to advance Alzheimer’s research with innovative tools Cambridge Cognition Holdings plc has expanded its partnership...
New partnership to advance precision medicine in lung cancer diagnosis Biofidelity and CellCarta have announced a strategic...
Promising results from mouse study lead to expanded trials Oxford Drug Design, the Oxford-based AI drug discovery...
Funds to accelerate commercialisation and clinical trials of diagnostic tests Owlstone Medical has announced a first close...
Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from The Michael...
First-in-human trial of PTD802 to commence following UK MHRA approval Pheno Therapeutics Limited has received clinical trial...
Companies aim to provide new treatments for inflammatory conditions Gilead Sciences and LEO Pharma have announced a...
Survey finds AI to enhance productivity and cut costs in the next 12 months AI is poised...
Debra is late getting up for work again. In her heart of hearts, she’s not really enjoying...
Groundbreaking approval provides new hope for patients in England and Wales The National Institute for Health and...
CR-discovered NXP800 shows promise in clinical trials Prostate cancer resistant to hormone therapy could soon have a...
Investment to support RNA therapeutics for epilepsy and neurological disorders Angelini Ventures has co-led a €20 million...
New FDA-approved schizophrenia treatment shows promise in clinical trials Cambridge Cognition has praised Bristol Myers Squibb for...
M-Trust set to improve product safety and counterfeiting solutions Merck has launched the beta version of M-Trust,...
OAV101 IT expands potential for type II SMA patients Novartis has announced that its intrathecal (IT) formulation...
IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer The UK’s Medicines and Healthcare...
EpiSwitch PSE shows promise in reducing unnecessary procedures Kearney Urology Center has reported a 50% reduction in...
FDA gives green light to innovative device for liver conditions Sequana Medical NV has announced the US...
Government announces independent commission on social care The government has announced the creation of an independent commission...
MHRA urges caution over illegal medicines from beauty salons and social media The Medicines and Healthcare products...
New chemotherapy-free treatment shows promise for EGFR-mutated NSCLC Janssen-Cilag International NV, a Johnson & Johnson company, announced...
Phase 2a study shows promising antidepressant effects Beckley Psytech has announced positive topline results from its phase...
New CT-guided radiotherapy system offers personalised cancer treatment Berlin’s Diagnostisch Therapeutisches Zentrum (DTZ) has become the first...
First patient dosed in landmark trial for GAD treatment MindMed has announced the dosing of the first...
New treatment could revolutionise care for HAE patients Global biotechnology leader CSL has announced that the European...
Promising trial results support marketing authorisation application Minoryx Therapeutics and Neuraxpharm Group have announced that leriglitazone has...
Trial explores potential of therapy in treating multiple cancer types Bayer has begun a phase 1 clinical...
Promising results set stage for European marketing authorization Minoryx Therapeutics and Neuraxpharm Group have announced that leriglitazone...
Successful phase 1 study highlights potential of roginolisib iOnctura has announced promising results from the phase 1...
New findings presented at international SCWD conference CatalYm has announced promising new data on its lead drug...
New cell therapy shows potential in treating advanced blood disorder Cellenkos has unveiled new phase 1b data...
promising pre-clinical data on preventing cytokine release syndrome Poolbeg Pharma has unveiled encouraging pre-clinical study data for...
Trial results lead to new treatment option for lung cancer AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy...
New antibody therapy shows promise in managing condition Neuraxpharm Group has announced that the National Institute for...
Phase 3 trial indicates significant efficacy and safety for children and adolescents Teva Pharmaceutical Industries has presented...
Race to create first oral drug for obesity intensifies The competition to gain approval for the first...
Data highlights effectiveness of EVER001 in treating pMN Everest Medicines has announced promising results from the Phase...
Versant Ventures leads investment round to advance drug Antag Therapeutics has announced the closing of an €80...
Partnership aims to develop new radiopharmaceuticals for cancer treatment Orbit Discovery, based in Oxford, UK, and Evergreen...
Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute...
New SureSeq CLL + CNV V3 panel improves understanding of CLL OGT has announced the launch of...
Therapy for autoimmune disorder shows potential Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative...
Injection significantly reduces need for further treatment A new treatment for asthma and COPD attacks could revolutionise...
2024 ABPI Code update has launched – what’s next for pharma and QR codes? The long-anticipated update...
Curve Therapeutics has appointed Rab Prinjha as Chief R&D Officer Curve Therapeutics has appointed Rab Prinjha as Chief Research and Development (R&D) Officer....
How industry and the NHS can work together to bridge the diagnostic gap in COPD
How oncology therapies can stand out in a diverse, uncertain landscape The oncology field is rapidly evolving,...
Commit Biologics has appointed Mikkel Wandahl Pedersen as CSO Commit Biologics has announced the appointment of Mikkel...
Tessellate BIO has appointed Dr Lara Boyd as CBO Tessellate BIO has appointed Dr Lara Boyd as Chief Business...
There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing...
Mahony will continue as the UK government’s Life Sciences Investment Envoy The Department for Science, Innovation and...
The biotech will use the funding to drive sales of its first commercial product Cytomos has announced...
The MHRA has appointed Anthony Harnden as Chair The Medicine and Healthcare products Regulatory Agency (MHRA) has...
The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles Ardena has...
The King’s Fund has appointed Siva Anandaciva as Director of Policy, Events and Partnerships The King’s Fund...
The census found that 56% of people visit their GP for a UTI and 27% for thrush...
Somerset NHS Foundation Trust has appointed Dr Rima Makarem as Chair Somerset NHS Foundation Trust has appointed...
The companies will focus on mechanisms of action, dose selection and biomarker analyses Teva Pharmaceuticals and artificial...
Therapy shows high efficacy in initial trial phase AC Immune SA has reported encouraging interim results from...
First participant vaccinated in study of ovx836 booster dose Osivax, a biopharmaceutical company developing vaccines for broad-spectrum...
New long-term partnership to address neurological disorder treatments Vivolta, a specialist in medical electrospinning solutions, has entered...
First patient dosed in phase 1b trial of MB310 therapy Microbiotica, a clinical-stage biopharma company, has announced...
Insight into double-blind, phase i/ii clinical trial for oesophageal cancer Infinitopes, an integrated cancer biotech firm, will...
Eco-friendly inhalers aim to reduce environmental impact Lupin Healthcare UK Ltd has announced plans to reformulate its...
First car t-cell therapy accepted for second-line treatment in Scotland The Scottish Medicines Consortium (SMC) has approved...
New treatment option approved for women in Scotland The Scottish Medicines Consortium (SMC) has recommended Yselty (linzagolix)...
New initiatives to tackle AI-related challenges in life sciences Elsevier, a leader in information and analytics, has...
Trial to evaluate safety and efficacy of MVA-BN vaccine A new scientific trial evaluating Bavarian Nordic’s mpox...
New therapy targets specific genetic alterations, promises extended survival Johnson & Johnson has announced that the UK’s...
Phase 1 and 2 studies show promising results for anito-cel therapy Arcellx Inc, a biotechnology firm focused...
AstronauTx has appointed Dr Jane Rhodes as Chief Executive Officer AstronauTx has appointed Dr Jane Rhodes as Chief Executive Officer (CEO) and member...
Importance of continuous collaboration with rare disease communities At Blueprint Medicines, we aim to make a significant...
Building strong partnerships with sites for more effective clinical trials When I first entered the clinical research...
Walgreens Boots Alliance appoints Anthony Hemmerdinger as MD, UK and Ireland Walgreens Boots Alliance has announced the appointment of Anthony Hemmerdinger as...
The new Dementia Trials Accelerator is set to receive £20m of government funding The Dementia Trials Accelerator,...
Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020 The National Institute...
Approximately 8.2 million people were diagnosed with the infectious disease in 2023 The World Health Organization’s (WHO)...
danicopan shown to improve haemoglobin levels and reduce anaemia Alexion, AstraZeneca Rare Disease, announced that the National...
Chiesi Group has appointed Laura Vergani as SVP of Global Communications Chiesi Group has announced that Laura...
CAL101 shows promising results and is set to enter phase 2 development Calluna Pharma AS has announced...
New treatment option for patients with newly diagnosed multiple myeloma The European Commission has approved the subcutaneous...
Innovative Trials has appointed Ian Keith as Finance and Business Services Director Innovative Trials has appointed Ian...
The company’s workforce will volunteer and fundraise for Team Jak throughout the year Valneva Scotland has partnered...
The five new programmes are designed to fit alongside full-time work and clinical practice Learna and the...
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK The...
The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma Vivan Therapeutics...
The two-year programme will use virtual reality technology to teach essential skills A £4.5m initiative has been...
NK:IO has appointed Richard Hopkins as Chief Executive Officer NK:IO has appointed Richard Hopkins, an experienced biologics...
There are around 55,100 new prostate cancer cases in the UK every year HBC Immunology (HBCI) has...
Partnership to harness AI for DUB-focused preclinical programmes
Study reveals potential new strategy for managing inflammatory bowel disease
Phase 2 study of TG4001 shows promise in cervical cancer patients Transgene, a biotech company specializing in...
Acquisition to enhance Lundbeck’s neuroscience pipeline Lundbeck has announced a significant step forward in its Focused Innovator...
New vaccine aims to protect older adults from severe flu complications Sanofi has announced the launch of...
Teclistamab offers hope for patients exhausting treatment options Teclistamab (Tecvayli), a drug manufactured by Johnson & Johnson,...
Sheffield cardiologists demonstrate cutting-edge TAVI procedure Cardiologists at Sheffield Teaching Hospitals NHS Foundation Trust have performed a...
New investment to advance gene therapies for kidney diseases Purespring Therapeutics has raised £80m in an oversubscribed...
AviadoBio to receive up to £1.8 billion in potential payments AviadoBio and Astellas Pharma have entered into...
Real-world studies show effectiveness of mogamulizumab in routine practice Kyowa Kirin International (KKI) has announced positive interim...
Scottish Medicines Consortium recommends pembrolizumab The Scottish Medicines Consortium (SMC) has recommended MSD’s KEYTRUDA (pembrolizumab) as a...
Biotech company moves forward with phase 2 trial for precision cancer surgery Copenhagen-based biotech company FluoGuide A/S...
Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid AlzeCure Pharma AB, a company...
Largest real-world study demonstrates significant survival advantage In a landmark study, Johnson & Johnson has announced that...
Phase 1 trial of IRL757 demonstrates good absorption and safety profile IRLAB Therapeutics AB has announced the...
ISM001-055 shows promise in improving lung function among patients Insilico Medicine, a clinical-stage generative AI-driven drug discovery...
Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has...
ICON celebrates 2024 ‘company of the year’ win ICON continues to celebrate its achievement at the 2024...
Harnessing vital patient data for precision in clinical trials In clinical research, leveraging patient data has become...
Sphere Fluidics has appointed Dr Alex Dickinson to its Board of Directors Sphere Fluidics has announced the appointment...
minds + assembly has appointed Fabio Gratton as an Advisor minds + assembly welcomes Fabio Gratton as...
New government scheme to offer routine opt-out blood tests Starting next week, Sheffield’s Northern General Hospital A&E...
£3m programme to accelerate new antimicrobial treatment Oxford Drug Design has been awarded a share of a...
4basebio has announced Dr Amy Walker as Chief Operating Officer 4basebio has announced the appointment of Dr...
International trial marks leap forward in chemotherapy-induced neuropathy care In a landmark announcement from Paris, AlgoTherapeutix (AlgoTx)...
International think tanks to shape future of cancer research funding Cancer Grand Challenges, a pioneering initiative co-founded...
Milieu Insight has appointed Sundip Chahal as Chief Executive Officer Milieu Insight has appointed Sundip Chahal (pictured...
There is currently no national screening programme for the disease in the UK Oncologica has developed a...
The conference will return to Vienna AirportCity on 23 to 24 October 2024 Samedan has announced that...
It is hoped that the tool will improve the diagnostic pathway and free up radiologists’ time Leeds...
Alchemab has appointed Jane Osbourn as Chief Executive Officer Alchemab Therapeutics has appointed Jane Osbourn, the company’s...
The centre aims to discover new drug targets for diseases such as Parkinson’s and hypertension The UK...
ABPI has appointed Russell Abberley as Acting President The Association of the British Pharmaceutical Industry (ABPI) has...
The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex The World Health Organization (WHO)...
Innovative immunotherapy drug HTL0039732 shows potential in trials Nxera Pharma and Cancer Research UK are set to...
GlobalData emphasises importance of Improved clinical trials World Sepsis Day, observed annually on 13 September, aims to...
Chemistry is the cornerstone of modern civilisation, playing a crucial role in virtually every aspect of our...
Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has...
New study highlights potential benefits of menopausal hormone therapy A recent study published in the American Journal...
